Dead Cat Bounce or Drowning? GWAV’s Nasdaq Notice Spells Trouble.
Greenwave Technology Solutions, Inc. (GWAV) Gets a Nasdaq Slap on the Wrist: Will They Sink or Swim? Welcome back to the ongoing saga of Greenwave...











Greenwave Technology Solutions, Inc. (GWAV) Gets a Nasdaq Slap on the Wrist: Will They Sink or Swim? Welcome back to the ongoing saga of Greenwave...
Liberty Media’s Live Split: $1.15 Billion Says They’re Serious (Updated May 30, 2025) Welcome back to the ongoing saga of Liberty Media, folks! Consider this...
FTAI Infrastructure Inc. Shakes Things Up (Slightly): New Directors and Auditors Elected at 2025 AGM Consider this your definitive guide to FTAI Infrastructure Inc.’s (FIP)...
Fate Therapeutics Stock: Board Shakeup, Share Explosion, and Incentive Overhaul – What’s Cooking? Welcome back to the ongoing saga of Fate Therapeutics (FATE), where we...
89bio, Inc. Shareholders Give a Resounding “Yes!” at 2025 Annual Meeting Welcome back to the ongoing saga of 89bio, Inc. (ETNB)! Consider this your definitive...
Eversource Energy Cashes In: $1.2 Billion Stock Sale – What’s Up With That? Welcome back to the ongoing saga of Eversource Energy, the electric company...
Equifax Exec Jumps Ship: Is the Data Breach Déjà Vu Back? (8-K Analysis, May 30, 2025) Welcome back to your regularly scheduled Equifax existential crisis...
Golden Parachutes & Non-Competes: Decoding Direct Digital Holdings’ (DRCT) Latest 8-K Welcome back to your regularly scheduled deep dive into the fascinating world of Direct...
DocuSign Shareholders Give Exec Pay a Side-Eye While Rubber-Stamping Everything Else Welcome back to the ongoing saga of deciphering DocuSign’s SEC filings – your favorite...
Chevron Dodges Bullets (and Stockholder Proposals) in Latest 8-K Welcome back to the ongoing saga of Chevron Corporation (CVX), the oil giant that’s always good...
Coupang Executive Shuffle: Kang Out, New Mystery Role In? 🤨 Welcome back to the ongoing saga of Coupang, Inc. (CPNG), the South Korean e-commerce giant...
CooperCompanies’ Q2 2025: Record Revenue, But a Material Weakness Looms 🚩 Welcome back to the ongoing saga of CooperCompanies (Nasdaq: COO) (COO), folks! Consider this...
CKPT and Sun Pharma: It’s Official! (Plus, Those Sweet, Sweet CVRs) Welcome back to the ongoing saga of Checkpoint Therapeutics (CKPT), dear readers. Consider this...